BRIGHTON, N.Y. – The Golisano Institute celebrated a significant milestone with the graduation of its inaugural class. More than 20 young entrepreneurs walked the stage at the Brighton campus.
Each graduate received a custom Golisano Institute blazer designed by Adrian Jules. Many graduates expressed their ambitions to start businesses, launch products, and make a real impact on the world.
“Lean in. Lean all the way in. You’re going to get what you get out of it, and it’s worth it. Every single moment is worth it, every single up, every single down. It’s an accelerated program, it’s not easy,” said one graduate. “But at the end of the day the accomplishment that you feel, the family vibe that we have here in unmatched.”
The two-year program costs $8,900 per year. Graduates earn a certificate in business and entrepreneurship. Registration is now open for fall programs.
To learn more or register, click here. Classes start up again on September 8.
RELATED: Fisher becomes latest school to partner with the Golisano Institute
AI assisted with the formatting of this story. Click here to see how WHEC News10NBC uses AI.
Golisano Institute celebrates inaugural class of young entrepreneurs at graduation ceremony WHEC.com.
Hence then, the article about golisano institute celebrates inaugural class of young entrepreneurs at graduation ceremony was published today ( ) and is available on News10NBC ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Golisano Institute celebrates inaugural class of young entrepreneurs at graduation ceremony )
Also on site :
- commercetools Kicks Off NRF 2026 - including Updates on Stripe ACS, AI Hub, and Helping Enterprises Stay Discoverable and Shoppable in Agentic Commerce
- inDrive turns to ads and groceries to diversify revenue
- Clover Initiates Phase 2 Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates